NICE's final appraisal indicates that Roche has offered the NHS a discount on the drug, which carrie...
Read moreAs facilitators we can help companies understand what payer evidence is required to demonstrate the ...
Read moreThe collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...
Read moreThe only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read moreNICE has recently developed the META tool, to support MedTech manufacturers in the identification of...
Read moreSince 29 July 2016 NICE) has employed a new fast-track appraisal process for oncology drugs.
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreThe new NICE oncology appraisal process aims to enable fast-track appraisals, allowing earlier acces...
Read moreEarlier this year, the UK government announced support for three new specialist centres capable of c...
Read more